From heartbreak to career-defining milestones, Savannah Guthrie's life story reveals her rise at "Today," and the resilience ...

In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press ...